M. Boy

Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor

Christina Charles‐Schoeman, Pierre Wicker, Miguel Á. González‐Gay et al. · Seminars in Arthritis and Rheumatism · 2016 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients

Robert H. Six, R.G Clemence, C.A Thomas et al. · Veterinary Parasitology · 2000 · 96 citations

Veterinary Medicine, Pharmacotherapy, Veterinary Pharmacology +4

Risk Factors for Major Adverse Cardiovascular Events in Phase <scp>III</scp> and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

Christina Charles‐Schoeman, Ryan DeMasi, Hernán Valdez et al. · Arthritis & Rheumatology · 2019 · 74 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Comparison between diagnostic ultrasonography and radiography in the evaluation of horses and cattle with thoracic disease: 56 cases (1984-1985)

Virginia B. Reef, M. Boy, Charles F. Reid et al. · Journal of the American Veterinary Medical Association · 1991 · 67 citations · Full text

Veterinary Medicine, Veterinary Diagnostic Imaging, Veterinary Pathology +17

Pharmacokinetics of tofacitinib, a janus kinase inhibitor, in patients with impaired renal function and end‐stage renal disease

Sriram Krishnaswami, Vincent Chow, M. Boy et al. · The Journal of Clinical Pharmacology · 2013 · 59 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +11